Melbourne, Victoria, Australia UniSuper is the famous Corporate Investor, which was founded in 2000. The venture was found in Australia. The main office of represented Corporate Investor is situated in the Melbourne.
The standard case for the fund is to invest in rounds with 1 partaker.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. The common things for fund are deals in the range of more than 100 millions dollars.
For fund there is no match between the location of its establishment and the land of its numerous investments - New Zealand. Among the most popular fund investment industries, there are Forestry, Commercial. Among the most popular portfolio startups of the fund, we may highlight Taumata Plantations, Taumata Plantations.
Related Funds
| Fund Name | Location |
| Bridge Builders Collaborative | Minneapolis, Minnesota, United States |
| Changjiang Securities | China, Hubei, Wuhan |
| DealerSocket | California, San Clemente, United States |
| Felix Capital | England, London, United Kingdom |
| H2020-SME-Instrument program | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| Jiedaibao | Beijing, Beijing, China |
| London Development Agency (LDA) | England, London, United Kingdom |
| Movens Ventures | - |
| One Peak Partners | England, London, United Kingdom |
| Techstars Austin Accelerator | Austin, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kinoxis Therapeutics | $10M | 12 Aug 2024 | Melbourne, Victoria, Australia | ||
Diraq | $7M | 25 Jun 2024 | Sydney, New South Wales, Australia | ||
Aravax | $22M | 23 Jan 2024 | Melbourne, Victoria, Australia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kinoxis Therapeutics | $10M | 12 Aug 2024 | Melbourne, Victoria, Australia | ||
Diraq | $7M | 25 Jun 2024 | Sydney, New South Wales, Australia | ||
Aravax | $22M | 23 Jan 2024 | Melbourne, Victoria, Australia |
